Global lyophilisation for pharmaceuticals market was valued at 1619 Million US$ in 2018 and is projected to reach 2204 Million US$ by 2024
Lyophilisation for pharmaceuticals contains Lyophilisation equipment and Services. Lyophilisation process is used by pharmaceutical and biotech manufacturing industries in order to expand the life span and reduce the damage to sensitive products such as enzymes, antibodies, blood plasma, proteins and vaccines.
Lyophilisationn process is used by pharmaceutical and biotech manufacturing industries in order to expand the life span and reduce the damage to sensitive products such as enzymes, antibodies, blood plasma, proteins and vaccines. Various technological advancements and increasing risk of contamination of high value pharmaceutical products are few of the factors contributing to the growth of the global Lyophilisationn equipment and services market. It is vital for every pharmaceutical organization to maintain the function and efficacy of the drug molecule and prevent it from damage.
Global lyophilisation for pharmaceuticals market was valued at 1619 Million US$ in 2018 and is projected to reach 2204 Million US$ by 2024, at a CAGR of 5.28% during the forecast period.
Global lyophilisation equipment and services market is segmented by equipment type into manifold freeze dryer, tray lyophilizers, rotary lyophilizers and freeze-drying microscopes etc.
Rotary Lyophilizers accounted for the largest share of more than 35% of the overall Lyophilisationn equipment market in 2018. The segment is also expected to maintain its lead during the forecast period through 2018 to 2024. Factors that have contributed towards the large market size of rotary lyophilizers are vast usage in large scale production systems and long-term stability of pharmaceutical products.
Furthermore, lyophilisationn services are classified into cycle development, aseptic filling and bulk lyophilisationn. among these mentioned products, bulk lyophilisationn accounted for largest market share in 2018 and is expected to grow at an approximate cagr of over 6.5%. The major factors responsible for such growth of this segment are cost affordability and large volume drying. Similarly, based on applications, the lyophilisationn equipment and services market is segmented into pharmaceuticals, biopharmaceuticals, diagnostics and nutraceuticals.